HARMONY ALLIANCE FOUNDATION

Enabling Data
Fostering Collaboration
Transforming Patient Care 

The HARMONY Platform

Turning complex hematology data into powerful insights

The Data

High-quality and high-volume data is the driving force behind the HARMONY Platform engine. In our modern society, data has become the new gold, but in the field of haematology, it’s more than that: it’s a lifeline. This is why the HARMONY Alliance Foundation offers access to curated records for accelerated collaborative research.

Find out how to access our comprehensive, high-quality data lake and become part of a growing network that is building the largest collaborative resource for hematologic malignancy research.

The Network

Explore collaboration without borders: 100+ organizations worldwide, and still expanding.
By pooling expertise and data from research institutions across the globe, we are creating a uniquely rich environment for research, enabling breakthroughs in haematological malignancies, and setting a new standard for data-driven innovation in healthcare.

The Research

Advancing the understanding of haematological malignancies

We offer an innovative framework to transform the treatment of haematological malignancies through access to vast amounts of data and cutting-edge analytics.

With a strong focus on AML, MM, ALL, and CML, we remain open to future collaborations across other disease areas—driving progress together through data, expertise, and shared purpose.

News

We attended DARWIN EU Data Partners’ meeting

1 December 2025. Reflecting on two inspiring days at EMA and Erasmus MC!…

HARMONY Alliance Foundation at this year’s ELN Breakfast Meeting

12 November 2025. In the framework of the annual ASH Meeting, on December 7th, HARMONY experts will offer an overview of ongoing projects and future plans during ELN Breakfast Meeting…

Learn about our three oral presentations at ASH

6 November 2025. ASH 2025: The HARMONY Alliance Foundation will be present in this key event for hematology research…

We are collaborating with world-leading companies to speed up new treatment options for patients with blood cancers

Partners

Collaborators

Do you work in a pharma company or SME?

Are you looking for real world evidence
to support your research?

Spain

  • PETHEMA – Programa Español de Tratamientos en Hematología
  • Jose Carreras Leukemia Research Institute
  • Spanish CETLAM Cooperative Group
  • Hospital 12 de Octubre – i+12 Instituto de Investigación
  • Hospital Universitario La Fe
  • Fundació Institut Mar D´Investigacions Mèdiques
  • Complejo Asistencial Universitario de Burgos
  • Ramon y Cajal University Hospital
  • Infanta Leonor Hospital
  • Costa del Sol Hospital
  • Hospital General Universitario Valencia
  • Catalan Registry of CML
  • Hospital Universitario de Gran Canaria Doctor Negrín
  • GESMD – Grupo Español de Síndromes Mielodisplásicos
  • FICUS – Fundación de Investigación del Cáncer de la Universidad de Salamanca / CIC Salamanca
  • Registro Gammapatías Castilla y León